CYCLACEL PHARMACEUTICALS INC's ticker is CYCCP and the CUSIP is 23254L207. A total of 2 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $66 | -79.4% | 6 | -73.9% | 0.00% | – |
Q1 2023 | $321 | -92.0% | 23 | -95.8% | 0.00% | – |
Q3 2022 | $4,000 | 0.0% | 548 | +8.9% | 0.00% | – |
Q2 2022 | $4,000 | 0.0% | 503 | -20.0% | 0.00% | – |
Q1 2022 | $4,000 | 0.0% | 629 | -7.1% | 0.00% | – |
Q4 2021 | $4,000 | -82.6% | 677 | -82.6% | 0.00% | – |
Q1 2020 | $23,000 | +15.0% | 3,891 | -4.3% | 0.00% | – |
Q4 2019 | $20,000 | 0.0% | 4,067 | -8.2% | 0.00% | – |
Q3 2019 | $20,000 | +81.8% | 4,428 | +98.7% | 0.00% | – |
Q2 2019 | $11,000 | 0.0% | 2,228 | -7.7% | 0.00% | – |
Q1 2019 | $11,000 | -8.3% | 2,415 | +4.3% | 0.00% | – |
Q4 2018 | $12,000 | +9.1% | 2,315 | +7.0% | 0.00% | – |
Q3 2018 | $11,000 | -26.7% | 2,164 | 0.0% | 0.00% | – |
Q2 2018 | $15,000 | +15.4% | 2,164 | +0.0% | 0.00% | – |
Q1 2018 | $13,000 | +225.0% | 2,163 | +279.5% | 0.00% | – |
Q4 2017 | $4,000 | +100.0% | 570 | +111.1% | 0.00% | – |
Q3 2017 | $2,000 | -50.0% | 270 | -55.7% | 0.00% | – |
Q1 2017 | $4,000 | -66.7% | 609 | -69.0% | 0.00% | – |
Q4 2016 | $12,000 | +140.0% | 1,965 | +186.4% | 0.00% | – |
Q3 2016 | $5,000 | -44.4% | 686 | -52.8% | 0.00% | – |
Q2 2016 | $9,000 | +200.0% | 1,454 | +144.8% | 0.00% | – |
Q1 2016 | $3,000 | +200.0% | 594 | +266.7% | 0.00% | – |
Q4 2015 | $1,000 | 0.0% | 162 | -0.6% | 0.00% | – |
Q3 2015 | $1,000 | 0.0% | 163 | 0.0% | 0.00% | – |
Q2 2015 | $1,000 | 0.0% | 163 | -1.2% | 0.00% | – |
Q1 2015 | $1,000 | 0.0% | 165 | -4.1% | 0.00% | – |
Q4 2014 | $1,000 | – | 172 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |